Pediatrix Medical Group, Inc.

MD Healthcare Medical Care Facilities

Pediatrix Medical Group, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $1.9 billion, down 4.92% from fiscal 2024.

Revenue
+1.72%
EPS
−27.6%
Free cash flow
−14.4%
Total debt
−4.11%

Quarter to September 2026, against a year earlier

31.41 0.43 −1.35%
Market cap
$2.5B
P/E
17.1×
Fwd P/E
15.3×
Dividend yield
—
F-score
7/9
Altman Z
2.05
Beneish M
−2.86
Dividend safety
n/a

Pediatrix Medical Group, Inc. (MD) EV/Sales

Alert me on EV/Sales

As of 5 November 2026, Pediatrix Medical Group, Inc. (MD) trades at a EV/Sales of 1.3×. Over the past ten years it has ranged from 0.5× (July 2024) to 4.1× (December 2019); the current reading is higher than 39% of that period. That is in line with the Medical Care Facilities industry median of 1.4× and below the Healthcare sector median of 3.5×.

EV/Sales, daily

Embed this chart

Annual newest first

Period EV/Sales Change
FY2025 1.0× 46.36%
FY2024 0.7× 10.07%
FY2023 0.6× (32.69%)
FY2022 0.9× (38.21%)
FY2021 1.5× (1.54%)
FY2020 1.5× (10.10%)
FY2019 1.7× (41.42%)
FY2018 2.9× 35.60%
FY2017 2.1× (14.49%)
FY2016 2.5× (13.28%)

Quarterly newest first

Period EV/Sales Change
Sep 2026 1.1× (2.80%)
Jun 2026 1.1× 9.00%
Mar 2026 1.0× 4.08%
Dec 2025 1.0× 22.35%
43 more quarters

Against its own ten years

Low 0.5× High 4.1×
Ten-year median 1.6×
Current reading's percentile 43

EV/Sales against peers

What EV/Sales is

EV/Sales tells an investor how the value of a whole company, counting its debt and cash, compares with the sales it brings in.

((Stock Price × Shares (Basic, Weighted) (latest quarter)) + (Long Term Debt (Total) (latest quarter) + Current Part of Debt (latest quarter)) − Cash & Short Term Investments (latest quarter)) ÷ Revenue (TTM)

The full definition of EV/Sales →

More on MD